You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Coliti…

Article metrics

Article menu

Download PDFPDF

XML
Inflammatory bowel disease
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)

 

Online download statistics by month:

Online download statistics by month: January 2018 to March 2024

AbstractFullPdf
Jan 201812212223
Feb 2018431426114
Mar 201819619731
Apr 201811711918
May 201811311412
Jun 201813513615
Jul 201812212112
Aug 201894947
Sep 201831316
Oct 2018313120
Nov 2018383817
Dec 2018292910
Jan 2019322913
Feb 201925256
Mar 2019383815
Apr 2019313018
May 2019262422
Jun 2019272518
Jul 2019302620
Aug 2019373524
Sep 2019171818
Oct 2019211717
Nov 2019201718
Dec 2019322914
Jan 202026249
Feb 2020363323
Mar 2020222110
Apr 202026249
May 2020262523
Jun 202023249
Jul 2020262613
Aug 202020199
Sep 202020205
Oct 2020585621
Nov 202033319
Dec 2020212212
Jan 202116137
Feb 2021232219
Mar 2021222012
Apr 2021191910
May 2021181710
Jun 2021313112
Jul 202125267
Aug 2021201912
Sep 2021333111
Oct 2021292920
Nov 2021292819
Dec 202137326
Jan 2022353610
Feb 2022302911
Mar 202229239
Apr 202227259
May 2022252515
Jun 2022252710
Jul 202216152
Aug 202222225
Sep 2022272817
Oct 2022222114
Nov 2022272711
Dec 202223226
Jan 202321217
Feb 202324223
Mar 202316165
Apr 202317174
May 202351516
Jun 202317161
Jul 2023121216
Aug 2023191611
Sep 202312122
Oct 202310100
Nov 202324237
Dec 202324207
Jan 202424249
Feb 202416174
Mar 202424246
Total30532984992